| Journal | Stroke (Hoboken, N.J.) |
| Study Type | Randomized Trial |
| Population | Human participants |
This study explores a simple, cost-free positional intervention that could potentially improve outcomes in acute stroke patients during the critical window before mechanical thrombectomy. Given the time-sensitive nature of stroke care and the potential for widespread implementation, even modest improvements in collateral flow could translate to meaningful clinical benefits.
The DOWN-SUITE trial is a multicenter, randomized, open-label phase 2a/b study examining head-down tilt positioning at -15° (similar to Trendelenburg) versus standard positioning in 118 patients with acute ischemic stroke due to M1 middle cerebral artery occlusion undergoing mechanical thrombectomy. The intervention aims to augment cerebral collateral blood flow and improve penumbral survival through gravitational enhancement of cerebral perfusion pressure. The study will assess safety, feasibility, and efficacy outcomes with blinded endpoint evaluation across 7 Italian stroke centers.
“While the physiologic rationale is sound—gravity can indeed enhance cerebral perfusion pressure—I remain cautiously optimistic given the complexity of stroke pathophysiology and the numerous failed simple interventions in this space. The real-world implementation challenges and patient tolerance of sustained head-down positioning during emergency care will be particularly telling.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- What is head down tilt 15° (HDT15) positioning and how does it work in stroke patients?
- Which stroke patients are eligible for this HDT15 intervention?
- When should HDT15 positioning be initiated in the stroke care pathway?
- What are the potential risks or contraindications of HDT15 positioning in stroke patients?
- How might HDT15 positioning change current stroke treatment protocols if proven effective?
FAQ
What is head down tilt 15° (HDT15) positioning and how does it work in stroke patients?
HDT15 is a simple positioning therapy similar to Trendelenburg position where the patient’s head is tilted 15 degrees below horizontal. This positioning is theorized to augment cerebral collateral blood flow by using gravity to increase perfusion pressure to the brain, potentially improving blood supply to the penumbral tissue surrounding the stroke core.
Which stroke patients are eligible for this HDT15 intervention?
The DOWN-SUITE trial specifically targets patients with acute ischemic stroke caused by M1 segment middle cerebral artery occlusion who are candidates for mechanical thrombectomy. These are patients with large vessel occlusion strokes where collateral circulation is critical for maintaining viable brain tissue until recanalization can be achieved.
When should HDT15 positioning be initiated in the stroke care pathway?
Based on the study protocol, HDT15 positioning should be initiated in the emergency department immediately after randomization and stroke diagnosis. Early implementation is crucial as the intervention aims to preserve penumbral tissue and enhance collateral flow during the critical time window before mechanical thrombectomy.
What are the potential risks or contraindications of HDT15 positioning in stroke patients?
While the study aims to assess safety as a primary endpoint, potential concerns with head-down positioning could include increased intracranial pressure, aspiration risk, and cardiovascular stress. The trial’s safety monitoring will be essential to identify any adverse effects, though HDT15 is considered a low-cost, simple intervention with theoretical benefits.
How might HDT15 positioning change current stroke treatment protocols if proven effective?
If the DOWN-SUITE trial demonstrates safety and efficacy, HDT15 could be integrated as a simple, immediate intervention in emergency departments for large vessel occlusion strokes. This low-cost positioning therapy could serve as a bridge intervention to optimize collateral flow while patients are being prepared for mechanical thrombectomy, potentially improving recanalization success rates and clinical outcomes.